NovoCure Gross Profit 2014-2024 | NVCR

NovoCure gross profit from 2014 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
NovoCure Annual Gross Profit
(Millions of US $)
2023 $381
2022 $423
2021 $420
2020 $388
2019 $263
2018 $168
2017 $121
2016 $37
2015 $12
2014 $5
2013 $3
NovoCure Quarterly Gross Profit
(Millions of US $)
2024-03-31 $105
2023-12-31 $101
2023-09-30 $95
2023-06-30 $92
2023-03-31 $93
2022-12-31 $100
2022-09-30 $101
2022-06-30 $112
2022-03-31 $110
2021-12-31 $104
2021-09-30 $103
2021-06-30 $105
2021-03-31 $108
2020-12-31 $116
2020-09-30 $104
2020-06-30 $90
2020-03-31 $77
2019-12-31 $74
2019-09-30 $69
2019-06-30 $66
2019-03-31 $53
2018-12-31 $47
2018-09-30 $46
2018-06-30 $42
2018-03-31 $34
2017-12-31 $38
2017-09-30 $35
2017-06-30 $25
2017-03-31 $23
2016-12-31 $19
2016-09-30 $11
2016-06-30 $2
2016-03-31 $5
2015-12-31 $6
2015-09-30 $3
2015-06-30
2015-03-31 $1
2014-12-31
2014-09-30 $2
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $2.014B $0.509B
NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $125.903B 15.80
Cencora (COR) United States $47.741B 18.61
ICON (ICLR) Ireland $26.139B 24.68
DiDi Global (DIDIY) China $21.386B 0.00
Avantor (AVTR) United States $15.283B 22.50
CochLear (CHEOY) Australia $14.173B 0.00
Revvity (RVTY) United States $13.191B 23.14
Natera (NTRA) United States $13.190B 0.00
Medpace Holdings (MEDP) United States $12.644B 41.60
Viatris (VTRS) United States $12.466B 3.73
Charles River Laboratories (CRL) United States $10.809B 20.69
EUROFINS SCIENT (ERFSF) Luxembourg $9.137B 0.00
Solventum (SOLV) United States $8.860B 0.00
Sonic Healthcare (SKHHY) Australia $8.681B 0.00
HealthEquity (HQY) United States $7.198B 46.21
Organon (OGN) United States $5.431B 5.15
Bausch + Lomb (BLCO) Canada $5.256B 21.04
Doximity (DOCS) United States $5.107B 35.77
PACS (PACS) United States $4.437B 0.00
Life Times (LTH) United States $3.623B 37.96
Sotera Health (SHC) United States $3.369B 16.53
Surgery Partners (SGRY) United States $3.017B 27.60
GoodRx Holdings (GDRX) United States $2.859B 108.86
Agilon Health (AGL) United States $2.677B 0.00
Progyny (PGNY) United States $2.487B 42.82
AMN Healthcare Services Inc (AMN) United States $2.029B 8.04
Premier (PINC) United States $1.949B 8.34
BrightSpring Health Services (BTSG) United States $1.852B 0.00
Teladoc Health (TDOC) United States $1.757B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.566B 0.00
Alignment Healthcare (ALHC) United States $1.449B 0.00
Establishment Labs Holdings (ESTA) $1.226B 0.00
CareDx (CDNA) United States $0.749B 0.00
Embecta (EMBC) United States $0.722B 4.91
GeneDx Holdings (WGS) United States $0.717B 0.00
InnovAge Holding (INNV) United States $0.695B 0.00
Pediatrix Medical (MD) United States $0.680B 7.21
Auna S.A (AUNA) Luxembourg $0.568B 0.00
Sharecare (SHCR) United States $0.497B 0.00
QDM (QDMI) Hong Kong, SAR China $0.437B 11.45
COMPASS Pathways (CMPS) United Kingdom $0.430B 0.00
Enhabit (EHAB) United States $0.426B 42.50
ModivCare (MODV) United States $0.367B 6.87
Sonida Senior Living (SNDA) United States $0.345B 0.00
DocGo (DCGO) United States $0.310B 16.94
LifeMD (LFMD) United States $0.288B 0.00
MultiPlan (MPLN) United States $0.238B 0.00
Beauty Health (SKIN) United States $0.223B 0.00
Sera Prognostics (SERA) United States $0.212B 0.00
Ascend Wellness Holdings (AAWH) United States $0.204B 0.00
Biodesix (BDSX) United States $0.189B 0.00
So-Young (SY) China $0.111B 53.49
Pono Capital Two (PTWO) United States $0.068B 0.00
NeueHealth (NEUE) United States $0.044B 5.88
Co-Diagnostics (CODX) United States $0.043B 0.00
IceCure Medical (ICCM) Israel $0.035B 0.00
Oncology Institute (TOI) United States $0.031B 0.00
Nutex Health (NUTX) United States $0.029B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.025B 0.00
SeaStar Medical Holding (ICU) United States $0.024B 0.00
Singular Genomics Systems (OMIC) United States $0.023B 0.00
OncoCyte (OCX) United States $0.022B 0.00
KindlyMD (KDLY) $0.018B 0.00
BIMI Holdings (BIMI) United States $0.015B 0.00
TRxADE HEALTH (MEDS) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
ISpecimen (ISPC) United States $0.005B 0.00
DermTech (DMTK) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.004B 0.00
OpGen (OPGN) United States $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Assure Holdings (IONM) United States $0.002B 0.00